skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: /sup 3/H)pirenzepine and (-)-(/sup 3/H)quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes

Journal Article · · J. Pharmacol. Exp. Ther.; (United States)
OSTI ID:5578981

Studies show (/sup 3/H)PZ identified selectively a subpopulation of muscarinic binding sites compared to classical antagonists like (-)-(/sup 3/H)QNB in many central and peripheral tissues. We characterized the binding and regulation of selected antagonists to high-affinity (/sup 3/H)PZ (putative M1) and low-affinity PZ (putative M2) sites in rat cerebral cortex (predominantly M1) and heart (predominantly M2). Saturation isotherms of (/sup 3/H)PZ and (-)-(/sup 3/H)QNB were performed under various conditions. Guanyl-5'-yl-imidodiphosphate (30 microM) showed little effect on Kd (dissociation constant) or total binding capacity (total receptor density) values. Higher ionic strength buffers yielded lower affinity values for (/sup 3/H)PZ and (-)-(/sup 3/H)QNB. Kinetic studies confirmed high affinity Kd values seen in steady-state assays. We conducted inhibition studies of selected muscarinic antagonists including the reportedly cardioselective (putative M2) drug, AF-DX 116 (11-((2-(diethylamino)methyl-1-piperidinyl)-acetyl)-5, 11-dihydro-6H-pyrido(2,3-b)(1,4)-benzodiazepine-6-one), the reportedly M1 selective compound, PZ, and the classical antagonist (-)QNB, using (/sup 3/H)PZ and (-)-(/sup 3/H)QNB-labeled cerebral cortical and cardiac homogenates. Assays were done with and without guanyl-5'-yl-imidophosphate at 25 degrees C in 10 mM Na-K-phosphate, 50 mM Na-K-phosphate and modified Krebs-phosphate buffer. Studies showed antagonists generally had higher affinity in 10 mM Na-K-phosphate buffer, were insensitive to guanyl-5'-yl imidodiphosphate and had Hill values (nH) nearly equal to one. Cardiac PZ/(/sup 3/H)QNB curves were steep.

Research Organization:
Univ. of Arizona Health Sciences Center, Tucson
OSTI ID:
5578981
Journal Information:
J. Pharmacol. Exp. Ther.; (United States), Vol. 2
Country of Publication:
United States
Language:
English

Similar Records

/sup 3/H)pirenzepine and (-)-(/sup 3/H)quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes
Journal Article · Thu May 01 00:00:00 EDT 1986 · J. Pharmacol. Exp. Ther.; (United States) · OSTI ID:5578981

Characterization of muscarinic cholinergic receptor subtypes in human peripheral lung
Journal Article · Mon Feb 01 00:00:00 EST 1988 · J. Pharmacol. Exp. Ther.; (United States) · OSTI ID:5578981

Muscarinic cholinergic receptor binding sites differentiated by their affinity for pirenzepine do not interconvert
Journal Article · Thu May 01 00:00:00 EDT 1986 · J. Pharmacol. Exp. Ther.; (United States) · OSTI ID:5578981